Incumbency footprint / loaded awards
NOVA BIOMEDICAL CORP
Source set: USASpending · As of 2026-11-10. Coverage is limited to loaded award records.
UEI as published: LCFDHTGXB5J3
Active-award and obligated rollups are withheld: the agent-written rollup has no covered period or n field. A full federal footprint is not verified.
Loaded award records
| Incumbent / award | Agency | Obligated | Source end date | Provenance |
|---|---|---|---|---|
| NOVA BIOMEDICAL CORPW81K0025CA001 ↗ | Department of Defense | $335,697.12 | 2026-12-31Period of performance current end date (USASpending) | USASpendingCONT_AWD_W81K0025CA001_9700_-NONE-_-NONE-As of 2026-03-16 |
Upcoming source end dates
| Incumbent / award | Agency | Obligated | Source end date | Provenance |
|---|---|---|---|---|
| NOVA BIOMEDICAL CORPW81K0025CA001 ↗ | Department of Defense | $335,697.12 | 2026-12-31Period of performance current end date (USASpending) | USASpendingCONT_AWD_W81K0025CA001_9700_-NONE-_-NONE-As of 2026-03-16 |
Dates reflect the source record. Options and extensions exist; an end date does not establish that a contract will be recompeted, renewed, or terminated.